Landing
Why Are Fewer Companies Going Public in Australia?
The number of companies listing on the ASX has declined, driven by access to private capital, regulatory burdens, and market volatility. However, public markets still offer liquidity, visibility, and robust capital-raising opportunities.
A Message to Founders: A Shared Journey to 2025 – A Once in a Generation Opportunity
As we close this challenging year, let’s reflect on the resilience, lessons, and growth that brought us here. Founders, 2025 is your golden opportunity to innovate, scale, and thrive. Set your strategy, rest, and prepare to sprint into a year of unparalleled possibilities.
From Trash to Treasure: Inside Australia’s First Commercial Waste-to-Hydrogen Facility
Greenhill Energy’s pioneering waste-to-hydrogen facility marks a significant step in sustainable energy. This Australian innovation is transforming waste management into clean, valuable hydrogen, presenting investors with a unique, forward-thinking opportunity.
When Others Flee Biotech’s Winter, This Firm Sees Spring Around the Corner
In the midst of biotech’s downturn, a bold venture firm is seizing opportunities others overlook. Discover how Australia’s healthcare sector, fueled by government support and regulatory efficiency, is transforming into a biotech powerhouse.
Is the Innovation Bull Run Triggered?
Curious if we’re on the brink of an Innovation Bull Run? Key factors like interest rates, rising liquidity, increased investment, and market-driven election outcomes are all signals that could ignite market booms. Examining the Trump presidency’s impact on these elements sheds light on how today’s markets might be setting the stage for significant growth in innovative sectors.
The Future of AI in Drug Discovery: A New Dawn for Investors
AI is reshaping drug discovery, offering faster timelines, cost reductions, and higher success rates. Investors stand at the threshold of a transformative opportunity to drive impact and returns in life sciences.
The Resurgence and Reality of SPACs: A Balanced Perspective
SPACs, or ‘blank cheque companies,’ are once again capturing investor interest, offering a faster route to public markets. However, with high potential rewards come significant risks. Dive into this balanced perspective on SPACs.
The Next Generation of Founders: A Journey Beyond the Boardroom
The rise of serial founders signals a powerful shift in the startup world. With experience, financial independence, and a passion for impact, these seasoned entrepreneurs are redefining what it means to launch a startup.
40-Year Medical Drought Ends: This Aussie Biotech’s Breakthrough Could Save Millions
For four decades, the medical community has waited for a groundbreaking advancement in antibiotics. Now, an Australian biotech company is pioneering the first new class of anti-infectives since the 1980s, offering new hope in the fight against antibiotic resistance. With FDA recognition and substantial government backing, this could be the breakthrough that transforms global healthcare.
Backed By Leading Investment Groups and Family Offices
